Loading data for APM — first visit, this takes a few seconds.

Aptorum Group Ltd

NGM: APM · 실시간 가격 · USD
0.70
n/a (n/a)
종가 기준: Aug 19, 2026, 3:23 PM

Aptorum Group Ltd (APM) Stock Price, Analysis & Data

데이터 없음

매수호가0.5
시가총액570.06K
매출 (ttm)n/a
순이익 (ttm)-1.36M
베타0.17
EPS (ttm)-1.9
P/E (ttm)n/a
선행 P/E-0.99
P/B (ttm)0.02
P/S (ttm)n/a
Earnings Daten/a
매도호가0.83
거래량195,145
평균 거래량 (20일)81,270
시가0.70
전일 종가n/a
일중 범위0.60 - 0.74
52주 범위0.60 - 44.70
애널리스트n/a
목표주가n/a
배당n/a
배당락일n/a

APM 소개

Aptorum Group Limited, through its subsidiaries, a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases. Its pipeline products include SACT-1, a repurposed drug candidate, which is in phase 1 clinical trial to treat neuroblastoma and other cancer types; ALS-4, a repurposed small molecule, which is in phase 1 clinical trial for the t...

섹터 Healthcare
IPO 일자 Jul 17, 2026
직원 수 1
상장 거래소 NGM
티커 APM
전체 기업 정보

재무 실적

2025년 Aptorum Ltd의 매출은 0로, 전년 0 대비 undefined% 증가했습니다. 순이익은 -1.36M로, -68.06% 감소했습니다.

재무제표